Todd S. Thomson

Executive

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 1 saleFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€1.4M

Latest filing published 07 Jan 2026 for Actuate Therapeutics, INC., €1.4M. Read the official filing

Filing timeline

BuySale

Todd S. Thomson

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Todd S. Thomson: trading record in brief

Todd S. Thomson is a declared insider of Actuate Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 14 August 2024 to 5 January 2026, the count stands at 2 filings.

Sales make up the whole of the open-market record (1 sale, €1.4M). In 2026 alone, the filings show no purchases and 1 sale.

The latest filing, published on 7 January 2026, reports an open-market sale of €1.4M in Actuate Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.